Search

Search Results
Results 181 - 190 of 192 for Acting out
  • Modafinil Viatris
    Drug - 9 Feb 2024
    Consumer Medicine Information (CMI) about Modafinil Viatris intended for persons living in Australia.
  • Exelon Patch
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Exelon Patch intended for persons living in Australia.
  • Exelon
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Exelon intended for persons living in Australia.
  • Maxolon Tablets
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Maxolon Tablets intended for persons living in Australia.
  • Maxolon
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Maxolon (Metoclopramide hydrochloride) intended for persons living in Australia.
  • Anoro Ellipta
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Anoro Ellipta intended for persons living in Australia.
  • Bricanyl Turbuhaler
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Bricanyl Turbuhaler intended for persons living in Australia.
  • Evenity
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Evenity intended for persons living in Australia.
  • Solifenacin Viatris
    Drug - 7 Dec 2022
    Consumer Medicine Information (CMI) about Solifenacin Viatris intended for persons living in Australia.
  • Agrylin
    Drug - 23 Sep 2022
    Consumer Medicine Information (CMI) about Agrylin intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback